TY - JOUR
T1 - Clinical management of liver cyst infections
T2 - an international, modified Delphi-based clinical decision framework
AU - Duijzer, Renée
AU - Bernts, Lucas H P
AU - Geerts, Anja
AU - van Hoek, Bart
AU - Coenraad, Minneke J
AU - Rovers, Chantal
AU - Alvaro, Domenico
AU - Kuijper, Ed J
AU - Nevens, Frederik
AU - Halbritter, Jan
AU - Colmenero, Jordi
AU - Kupcinskas, Juozas
AU - Salih, Mahdi
AU - Hogan, Marie C
AU - Ronot, Maxime
AU - Vilgrain, Valerie
AU - Hanemaaijer, Nicolien M
AU - Kamath, Patrick S
AU - Strnad, Pavel
AU - Taubert, Richard
AU - Gansevoort, Ron T
AU - Torra, Roser
AU - Nadalin, Silvio
AU - Suwabe, Tatsuya
AU - Gevers, Tom J G
AU - Cardinale, Vincenzo
AU - Drenth, Joost P H
AU - Lantinga, Marten A
PY - 2024/9
Y1 - 2024/9
N2 - Liver cyst infections often necessitate long-term hospital admission and are associated with considerable morbidity and mortality. We conducted a modified Delphi study to reach expert consensus for a clinical decision framework. The expert panel consisted of 24 medical specialists, including 12 hepatologists, from nine countries across Europe, North America, and Asia. The Delphi had three rounds. The first round (response rate 21/24 [88%]) was an online survey with questions constructed from literature review and expert opinion, in which experts were asked about their management preferences and rated possible management strategies for seven clinical scenarios. Experts also rated 14 clinical decision-making items for relevancy and defined treatment outcomes. During the second round (response rate 13/24 [54%]), items that did not reach consensus and newly suggested themes were discussed in an online panel meeting. In the third round (response rate 16/24 [67%]), experts voted on definitions and management strategies using an online survey based on previous answers. Consensus was predefined as a vote threshold of at least 75%. We identified five subclassifications of liver cyst infection according to cyst phenotypes and patient immune status and consensus on episode definitions (new, persistent, and recurrent) and criteria for treatment success or failure was reached. The experts agreed that fever and elevated C-reactive protein are pivotal decision-making items for initiating and evaluating the management of liver cyst infections. Consensus was reached on 26 management statements for patients with liver cyst infections across multiple clinical scenarios, including two treatment algorithms, which were merged into one after comments. We provide a clinical decision framework for physicians managing patients with liver cyst infections. This framework will facilitate uniformity in the management of liver cyst infections and can constitute the basis for the development of future guidelines.
AB - Liver cyst infections often necessitate long-term hospital admission and are associated with considerable morbidity and mortality. We conducted a modified Delphi study to reach expert consensus for a clinical decision framework. The expert panel consisted of 24 medical specialists, including 12 hepatologists, from nine countries across Europe, North America, and Asia. The Delphi had three rounds. The first round (response rate 21/24 [88%]) was an online survey with questions constructed from literature review and expert opinion, in which experts were asked about their management preferences and rated possible management strategies for seven clinical scenarios. Experts also rated 14 clinical decision-making items for relevancy and defined treatment outcomes. During the second round (response rate 13/24 [54%]), items that did not reach consensus and newly suggested themes were discussed in an online panel meeting. In the third round (response rate 16/24 [67%]), experts voted on definitions and management strategies using an online survey based on previous answers. Consensus was predefined as a vote threshold of at least 75%. We identified five subclassifications of liver cyst infection according to cyst phenotypes and patient immune status and consensus on episode definitions (new, persistent, and recurrent) and criteria for treatment success or failure was reached. The experts agreed that fever and elevated C-reactive protein are pivotal decision-making items for initiating and evaluating the management of liver cyst infections. Consensus was reached on 26 management statements for patients with liver cyst infections across multiple clinical scenarios, including two treatment algorithms, which were merged into one after comments. We provide a clinical decision framework for physicians managing patients with liver cyst infections. This framework will facilitate uniformity in the management of liver cyst infections and can constitute the basis for the development of future guidelines.
U2 - 10.1016/S2468-1253(24)00094-3
DO - 10.1016/S2468-1253(24)00094-3
M3 - (Systematic) Review article
SN - 2468-1253
VL - 9
SP - 884
EP - 894
JO - The Lancet Gastroenterology and Hepatology
JF - The Lancet Gastroenterology and Hepatology
IS - 9
ER -